Skip to main content
. 2020 Jul 16;33(4):565–570. doi: 10.1097/MEG.0000000000001782

Fig. 1.

Fig. 1.

Transition of patients with minimal, moderate or advanced fibrosis from baseline to end of follow-up in NAFLD/PBC and NAFLD alone patients (as proportions). (a) Transition of FIB-4. (b) Transition of APRI. NAFLD, non-alcoholic fatty liver disease; PBC, primary biliary cholangitis.